Initial results from HCV pilot program in Vietnam
In Vietnam, a million people are infected with Hepatitis C (HCV). Without treatment, HCV can cause cirrhosis, liver cancer and even death. While no vaccines exist to prevent HCV, the virus is easily treated with directly-acting antivirals (DAAs). In 2017, CHAI worked with the Vietnamese government to pilot a national public sector HCV care and treatment program in order to increase access to DAAs and test real-world outcomes for those initiated on treatment. The initial results were presented at the Global Hepatitis Summit 2018 in Toronto in June.